(Q44938530)

7 December 2017

title

"Development of the proteasome inhibitor Velcade (Bortezomib)" by Julian Adams, Ph.D., and Michael Kauffman, M.D., Ph.D. (English)

1 reference

7 December 2017

Richard Bold

1

1 reference

7 December 2017

publication date

1 January 2004

1 reference

7 December 2017

1 reference

7 December 2017

volume

22

1 reference

7 December 2017

issue

2

1 reference

7 December 2017

page(s)

328-329

1 reference

Postischemic (6-Hour) treatment with recombinant human tissue plasminogen activator and proteasome inhibitor PS-519 reduces infarction in a rat model of embolic focal cerebral ischemia

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030223

Proteasome inhibition: A novel mechanism to combat asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030223

Regulation of synovial cell apoptosis by proteasome inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030223

Increased sensitivity of CLL-derived lymphocytes to apoptotic death activation by the proteasome-specific inhibitor lactacystin

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030223

21 January 2018

Identifiers

DOI

10.1081/CNV-120030223

1 reference

7 December 2017

1 reference